Point-of-care multiplex immunoassay system quantifying up to 8 biomarkers from 20-50 µl capillary blood in 15-20 minutes. CE-IVD and IVDR certified platform technology delivering laboratory-quality results for applications including vitamin D, TBE antibody, and COVID-19 IgG testing.
Manufactured by
Rainbach im Muehlkreis, Austria
GENSPEED Biotech GmbH – Rapid Multiplex Diagnostics in Laboratory Quality GENSPEED Biotech develops and manufactures rapid diagnostic tests that combine laboratory accuracy with true point-of-care convenience . Our proprietary GENSPEED® Multiplex Micro-ELISA Platform delivers quantitative, lab-quality results within 15–20 minutes from a single drop of capillary blood or other biological samples. The technology integrates microfluidics, chemiluminescence detection, and multiplexed ELISA chemistry in a compact, cartridge-based format. It enables simultaneous quantification of up to eight biomarkers, providing comprehensive diagnostic insights directly at the point of need — in pharmacies, doctors offices, clinics, and research laboratories. GENSPEED is IVDR-certified and already offers CE-marked assays such as the Vitamin D xPOC , FSME (TBE) IgG xPOC , COVID-19 IgG xPOC , and PerioPOC Pro tests. Current developments include multiplex assays for prosthetic joint infection (PJI) , process analytical testing for biopharmaceutical manufacturing (HEK293 HCP assay) and other applications. Our vision is to bring laboratory diagnostics to the point of care – enabling faster, data-driven medical decisions that improve patient outcomes and strengthen healthcare accessibility.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Biomerica, Inc.
United States · 1 relevant product
FARMASİNA TIBBİ VE KİMYEVİ ÜRÜN.SAN.VE TİC.LTD.ŞTİ
Türkiye · 1 relevant product
Diagnogen
Hong Kong · 1 relevant product
Sekbio Co., Ltd
China · 1 relevant product
bioactiva diagnostica GmbH
Germany · 1 relevant product
Quansys Biosciences
United States · 1 relevant product
YASEE BioMedical Inc.
China · 2 relevant products
FlashDx Shenzhen Inc.
China · 3 relevant products
Response Biomedical
Canada · 1 relevant product
S&T BioMed CO., LTD.
Taiwan · 2 relevant products
32 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →5 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 48 closest product alternatives
Biomerica, Inc. · United States
A point-of-care diagnostic platform supporting manual to high-throughput ELISA testing with easy automation capabilities. Enables laboratory-accurate results at the point-of-care.
FARMASİNA TIBBİ VE KİMYEVİ ÜRÜN.SAN.VE TİC.LTD.ŞTİ · Türkiye
Multiplex ELISA kit for simultaneous detection and quantification of multiple analytes in a single sample. Designed for clinical laboratories and research settings to enable efficient immunoassay testing with reduced sample volume and processing time.
Diagnogen · Hong Kong
A high-sensitivity enzyme-linked immunosorbent assay kit designed for complex biomarker detection with 99.9% specificity for modern diagnostic laboratories.
Sekbio Co., Ltd · China
High-throughput ELISA platform providing results in 1-4 hours with sandwich, competitive, and indirect assay formats in 96 or 384-well plate configuration. Offers high sensitivity at ng/mL range with cost-effective per-test performance.
bioactiva diagnostica GmbH · Germany
Enzyme-linked immunosorbent assay (ELISA) platforms for serological and immunological testing in clinical diagnostics. These standardized systems are designed for quantitative and qualitative detection of antigens and antibodies in various biological samples.
Quansys Biosciences · United States
Ready-to-use multiplex microplate kits that detect up to 18 biomarkers simultaneously for research applications. Available in pre-configured formats or customizable panels across human, mouse, and other species for disease understanding and biomarker analysis.
YASEE BioMedical Inc. · China
Portable microfluidic blood analysis system enabling point-of-care testing for rapid multi-parameter blood diagnostics. Integrates electrochemical and immunofluorescence detection technologies for glucose, pressure, and comprehensive health monitoring in clinical, pharmacy, and home settings.
FlashDx Shenzhen Inc. · China
Point-of-care multiplex nucleic acid detection system enabling rapid syndromic molecular testing at or near the patient location. Delivers sample-to-answer results for pathogen identification, supporting faster clinical decision-making in emergency, urgent care, and primary care settings. Integrates multiple targets in a single automated assay workflow.
Response Biomedical · Canada
Integrated point of care testing platform designed for rapid diagnostic analysis in clinical environments, supporting multiple biomarker assays for immediate patient assessment and decision-making.
S&T BioMed CO., LTD. · Taiwan
Automated immunoassay system utilizing electrochemical detection methods for biomarker quantification. Suitable for high-throughput clinical laboratory applications.
Healgen Scientific LLC · United States
Multiplexing BioChip for rapid, simultaneous detection of multiple analytes in clinical specimens. FDA 510(k) cleared platform enables high-throughput diagnostic testing including fentanyl, oral fluid biomarkers, and other substances of abuse. CLIA-waived assays deliver results in minutes for point-of-care and laboratory use.
FlashDx Shenzhen Inc. · China
A point-of-care molecular testing system built on FlashDx's proprietary semi-Solid Phase Real Time PCR (SPRT™) technology. The system delivers simple, fast, and comprehensive multiplexed molecular test results within one hour. It is designed for near-patient syndromic testing with a growing test menu and potential expansion to oncology and other disease areas.
36 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products